systemic lupus erythematosus

Early ILD Recognition in SARD/SSc: Drivers of Progression and Workflow Solutions

Early identification of interstitial lung disease (ILD) in systemic autoimmune rheumatic diseases (SARD) and systemic sclerosis (SSc) is critical.

Early SLE Disease Control: Targeting IFN Pathway at EULAR 2026

Achieving early disease control in systemic lupus erythematosus (SLE) is critical for preventing organ damage. Targeting the interferon (IFN) pathway offers a precise therapeutic strategy.

Treat-to-Target in SLE: Balancing Burden, Benefit, and Risk

Treat-to-target strategies in Systemic Lupus Erythematosus (SLE) aim for optimal disease control but introduce patient burden and potential risks.